Down-Regulation of eIF4GII by miR-520c-3p Represses Diffuse Large B Cell Lymphoma Development

Deregulation of the translational machinery is emerging as a critical contributor to cancer development. The contribution of microRNAs in translational gene control has been established however; the role of microRNAs in disrupting the cap-dependent translation regulation complex has not been previously described. Here, we established that elevated miR-520c-3p represses global translation, cell proliferation and initiates premature senescence in HeLa and DLBCL cells. Moreover, we demonstrate that miR-520c-3p directly targets translation initiation factor, eIF4GII mRNA and negatively regulates eIF4GII protein synthesis. miR-520c-3p overexpression diminishes cells colony formation and reduces tumor growth in a human xenograft mouse model. Consequently, downregulation of eIF4GII by siRNA decreases translation, cell proliferation and ability to form colonies, as well as induces cellular senescence. In vitro and in vivo findings were further validated in patient samples; DLBCL primary cells demonstrated low miR-520c-3p levels with reciprocally up-regulated eIF4GII protein expression. Our results provide evidence that the tumor suppressor effect of miR-520c-3p is mediated through repression of translation while inducing senescence and that eIF4GII is a key effector of this anti-tumor activity.

[1]  K. Mazan-Mamczarz,et al.  Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL). , 2013, Leukemia research.

[2]  I. Keklikoglou,et al.  MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways , 2012, Oncogene.

[3]  M. Serrano Dissecting the role of mTOR complexes in cellular senescence , 2012, Cell cycle.

[4]  Christopher J. Cheng,et al.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.

[5]  A. Bader,et al.  Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo , 2012, Leukemia.

[6]  A. Dejean,et al.  Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells , 2012, Nature Cell Biology.

[7]  Michael J. Wilson,et al.  miR‐520c and miR‐373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF‐κB factor in human fibrosarcoma cells , 2012, Journal of cellular physiology.

[8]  K. Naresh,et al.  BCL3 rearrangement, amplification and expression in diffuse large B‐cell lymphoma , 2011, European journal of haematology.

[9]  N. Shomron,et al.  Cancer, Senescence, and Aging: Translation from Basic Research to Clinics , 2011, Journal of aging research.

[10]  C. Stumpf,et al.  The cancerous translation apparatus. , 2011, Current opinion in genetics & development.

[11]  K. Mazan-Mamczarz,et al.  Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma , 2011, Nature communications.

[12]  J. Clohessy,et al.  Pro-senescence therapy for cancer treatment , 2011, Nature Reviews Cancer.

[13]  H. Rehrauer,et al.  Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. , 2011, Blood.

[14]  J. Chi,et al.  MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival , 2011, Biology Direct.

[15]  M. Gorospe,et al.  ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes. , 2011, Blood.

[16]  Ker-Chau Li,et al.  Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. , 2011, Cell host & microbe.

[17]  A. Willis,et al.  Translation deregulation in B-cell lymphomas. , 2010, Biochemical Society transactions.

[18]  C. Croce,et al.  MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application. , 2010, Cancer genetics and cytogenetics.

[19]  D. Pisano,et al.  MicroRNA signatures in B-cell lymphomas , 2010, Blood Cancer Journal.

[20]  David F Jarrard,et al.  Therapy-induced senescence in cancer. , 2010, Journal of the National Cancer Institute.

[21]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[22]  C. Bellodi,et al.  Deregulation of oncogene‐induced senescence and p53 translational control in X‐linked dyskeratosis congenita , 2010, The EMBO journal.

[23]  Huiling Yang,et al.  Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma , 2010, Molecular Cancer.

[24]  M. Narita,et al.  Connecting autophagy to senescence in pathophysiology. , 2010, Current opinion in cell biology.

[25]  R. Gartenhaus,et al.  Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. , 2010, Blood.

[26]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[27]  Y. Natkunam,et al.  Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma. , 2009, Cancer research.

[28]  K. Basso,et al.  Identification of the human mature B cell miRNome. , 2009, Immunity.

[29]  J. Chi,et al.  Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma , 2008, Journal of cellular and molecular medicine.

[30]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[31]  K. Mazan-Mamczarz,et al.  Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. , 2008, Cancer research.

[32]  S. Lowe,et al.  Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. , 2008, The Journal of clinical investigation.

[33]  J. Zavadil,et al.  eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy , 2008, The Journal of cell biology.

[34]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[35]  R. Aguiar,et al.  Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. , 2008, Cancer genetics and cytogenetics.

[36]  S. Lowe,et al.  Dissecting eIF4E action in tumorigenesis. , 2007, Genes & development.

[37]  Tao Wang,et al.  Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. , 2007, The Journal of clinical investigation.

[38]  A. Degterev,et al.  Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G , 2007, Cell.

[39]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[40]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[41]  V. Polunovsky,et al.  The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways , 2006, RNA biology.

[42]  P. Meltzer Cancer genomics: Small RNAs with big impacts , 2005, Nature.

[43]  N. Sonenberg,et al.  Selective Modification of Eukaryotic Initiation Factor 4F (eIF4F) at the Onset of Cell Differentiation: Recruitment of eIF4GII and Long-Lasting Phosphorylation of eIF4E , 2004, Molecular and Cellular Biology.

[44]  N. Sonenberg,et al.  Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.

[45]  P. Pandolfi,et al.  The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.

[46]  J. Graff,et al.  eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.

[47]  M. Clemens,et al.  Targets and mechanisms for the regulation of translation in malignant transformation , 2004, Oncogene.

[48]  J. Shay,et al.  Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.

[49]  S. Lowe,et al.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.

[50]  W. Klapper,et al.  Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.

[51]  F. Meric,et al.  Translation initiation in cancer: a novel target for therapy. , 2002, Molecular cancer therapeutics.

[52]  V. Ambros microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[53]  Myriam Gorospe,et al.  Loss of HuR Is Linked to Reduced Expression of Proliferative Genes during Replicative Senescence , 2001, Molecular and Cellular Biology.

[54]  H. Iro,et al.  Translation initiation factor eIF‐4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma , 2001, Cancer.

[55]  B. Woda,et al.  Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. , 1999, The American journal of pathology.

[56]  N. Sonenberg,et al.  A newly identified N‐terminal amino acid sequence of human eIF4G binds poly(A)‐binding protein and functions in poly(A)‐dependent translation , 1998, The EMBO journal.

[57]  N. Sonenberg,et al.  A Novel Functional Human Eukaryotic Translation Initiation Factor 4G , 1998, Molecular and Cellular Biology.

[58]  T. Fukuchi-Shimogori,et al.  Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.

[59]  A. Hagemeijer,et al.  t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. , 1997, Cancer genetics and cytogenetics.

[60]  N. Sonenberg,et al.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.

[61]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.